Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure [Phase 2]

View source ↗

Summary

Phase 2 autologous decidual-like natural killer cell therapy for reproductive failure is not yet recruiting; the trial targets missed abortion and unexplained i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous decidual-like NK cell therapy (autologous decidual-like natural killer cells)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Abortion, Missed, Infertility Unexplained | Phase 2 | Status: NOT_YET_RECRUITING